Rhino-Orbital-Cerebral Mucormycosis after Allogeneic Hematopoietic Stem Cell Transplantation and Isavuconazole Therapeutic Drug Monitoring during Intestinal Graft versus Host Disease.

Deferasirox Isavuconazole Liposomal amphotericin B Rhino-orbital-cerebral mucormycosis Therapeutic drug monitoring

Journal

Mediterranean journal of hematology and infectious diseases
ISSN: 2035-3006
Titre abrégé: Mediterr J Hematol Infect Dis
Pays: Italy
ID NLM: 101530512

Informations de publication

Date de publication:
2019
Historique:
received: 12 07 2019
accepted: 19 09 2019
entrez: 9 11 2019
pubmed: 9 11 2019
medline: 9 11 2019
Statut: epublish

Résumé

A diagnosis of rhino-orbital-cerebral mucormycosis was made in a 59-year-old man with a secondary acute myeloid leukemia a few days after hematopoietic stem cell transplantation. Prompt treatment with combined antifungal therapy (liposomal amphotericin B and isavuconazole) followed by a procedure of endoscopic sinus surgery resulted in the resolution of the infection. Therapeutic drug monitoring of isavuconazole was performed during the year of treatment showing an increment of plasma concentrations in correspondence with the improvement of intestinal GvHD, thus suggesting that in this or similar conditions TDM for isavuconazole can be of value. A literature review of cases of rhino-orbital-cerebral and rhino-cerebral mucormycosis in allogeneic hematopoietic stem cell transplant recipients was carried out.

Identifiants

pubmed: 31700586
doi: 10.4084/MJHID.2019.061
pii: mjhid-11-1-e2019061
pmc: PMC6827600
doi:

Types de publication

Case Reports

Langues

eng

Pagination

e2019061

Déclaration de conflit d'intérêts

Competing interests: The authors declare no conflict of Interest.

Références

Curr Infect Dis Rep. 2010 Nov;12(6):423-9
pubmed: 21308550
Mycopathologia. 2008 Jun;165(6):407-10
pubmed: 18340546
Antimicrob Agents Chemother. 2018 Apr 26;62(5):
pubmed: 29483124
Int J Hematol. 2016 Mar;103(3):354-5
pubmed: 26781616
Antimicrob Agents Chemother. 2018 Jun 26;62(7):
pubmed: 29735569
J Antimicrob Chemother. 2012 Mar;67(3):715-22
pubmed: 21937481
Antimicrob Agents Chemother. 2009 Jul;53(7):3122-5
pubmed: 19433555
Clin Otolaryngol. 2018 Dec;43(6):1454-1464
pubmed: 29947167
Pharmacotherapy. 2015 Nov;35(11):1037-51
pubmed: 26598096
Clin Lymphoma Myeloma Leuk. 2013 Oct;13(5):622-8
pubmed: 23850285
Mycoses. 2019 Mar;62(3):252-260
pubmed: 30565742
Clin Microbiol Infect. 2019 Jan;25(1):26-34
pubmed: 30036666
Clin Infect Dis. 2005 Sep 1;41(5):634-53
pubmed: 16080086
Curr Infect Dis Rep. 2012 Aug;14(4):423-34
pubmed: 22684277
J Antimicrob Chemother. 2019 Aug 1;74(8):2341-2346
pubmed: 31119272
J Antimicrob Chemother. 2017 Mar 1;72(suppl_1):i12-i18
pubmed: 28355463
Lancet. 2016 Feb 20;387(10020):760-9
pubmed: 26684607
Pediatr Infect Dis J. 2013 Oct;32(10):1149-50
pubmed: 24067555
J Pharm Biomed Anal. 2017 Oct 25;145:718-724
pubmed: 28806568

Auteurs

Giacomo Andreani (G)

Department of Clinical and Biological Sciences, University of Turin, San Luigi Gonzaga Hospital, Orbassano, Turin, Italy.

Gianluca Fadda (G)

Department of Otolaringology, San Luigi Gonzaga Hospital, Orbassano, Turin, Italy.

Dario Gned (D)

Department of Diagnostic Imaging, San Luigi Gonzaga Hospital, Orbassano, Turin, Italy.

Matteo Dragani (M)

Department of Clinical and Biological Sciences, University of Turin, San Luigi Gonzaga Hospital, Orbassano, Turin, Italy.

Giovanni Cavallo (G)

Department of Otolaringology, San Luigi Gonzaga Hospital, Orbassano, Turin, Italy.

Valentina Monticone (V)

Department of Otolaringology, San Luigi Gonzaga Hospital, Orbassano, Turin, Italy.

Alessandro Morotti (A)

Department of Clinical and Biological Sciences, University of Turin, San Luigi Gonzaga Hospital, Orbassano, Turin, Italy.

Marco De Gobbi (M)

Department of Clinical and Biological Sciences, University of Turin, San Luigi Gonzaga Hospital, Orbassano, Turin, Italy.

Angelo Guerrasio (A)

Department of Clinical and Biological Sciences, University of Turin, San Luigi Gonzaga Hospital, Orbassano, Turin, Italy.

Anna Maria Barbui (AM)

Microbiology and Virology Unit, Azienda Ospedaliera Universitaria Città della Salute e della Scienza, Turin, Italy.

Antonio D'Avolio (A)

Department of Medical Sciences, Laboratory of Clinical Pharmacology and Pharmacogenetics, University of Turin, Amedeo di Savoia Hospital, Turin, Italy.

Daniela Cilloni (D)

Department of Clinical and Biological Sciences, University of Turin, San Luigi Gonzaga Hospital, Orbassano, Turin, Italy.

Classifications MeSH